Senior Statistician - Rixensart, België - GSK

GSK

Geverifieerd bedrijf

Rixensart, België

1 week geleden

Geplaatst door:

Sophie Dubois

beBee Recruiter

Beschrijving

Site Name:
Belgium-Rixensart, Italy - Parma, Italy - Rosia, Italy - Siena, Italy - Verona

Posted Date:
Apr

Job Purpose:

When it comes to developing the Vaccines of the future, we're looking for real experts who are interested in working in the stimulating environment of an international healthcare company.

If you have strong ambition, solid technical skills and passion for innovation and global-working, and you want to make a difference to patients' lives then YOU could be the future of GSK Vaccines business.

As a Senior Statistician, you'll join a global team of CMC statistics experts to bring all aspects of non-clinical statistics in Technical Research & Development during product, process and analytical development, regulatory approval, technical transfer of new Vaccines.

You'll Influence internally and externally to adopt rigorous and sound statistical approaches which have large organizational, strategic and business impact.

Your responsibilities:

You act as essential partner for project technical teams (e.g. Technical Development Leader, functions representatives,) or other stakeholder groups and provide statistical expertise in all aspects of Technical Research & Development (Product, Process and Analytical Development and commercialization) bringing the added value of datadriven decisions.
You ensure full integration of statistics across functions into everyday work as appropriate based on a close and deep partnership with scientists. You ensure advanced statistical concepts are routinely being applied during the development of product (e.g. stability modelling), process (e.g. modelling and simulation of biopharmaceutical process) and analytical methods (e.g. bioassays development) to ensure competitive and state of the art quality and productivity.
You ensure high quality regulatory dossiers which set the benchmark in the industry and result in high regulatory acceptance.
You provide statistical expertise for all global development in compliance with current ICH / FDA, QbD guidelines and SOPs

_ Why you?_:

Basic Qualifications:

We are looking for professionals with these required skills to achieve our goals:_
University degree (Master / PhD) in Data Science, Statistics, Mathematics, or related field
Fluent English required; second language desirable (e.g. Italian, French)

Preferred Qualifications:

If you have the following characteristics, it would be a plus:_
Experience of working in global and agile cultural teams
Experience in crossfunctional teams
Ideally experience in Quality by Design as applied to biologics and vaccines
Ideally knowledge of vaccines industry, especially in the development, approval and commercialization of vaccine products
Continuous learning and entrepreneurial mindset to support implementation of GSK's digital strategy
Strong communication, collaboration and influencing skills

_ Why GSK?_:

Uniting science, technology and talent to get ahead of disease together

GSK is a global biopharma company with a special purpose - to unite science, technology and talent to get ahead of disease together - so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns - as an organisation where people can thrive.

Getting ahead means preventing disease as well as treating it, and we aim to impact the health of 2.5 billion people around the world in the next 10 years.

Our success absolutely depends on our people.

While getting ahead of disease together is about our ambition for patients and shareholders, it's also about making GSK a place where people can thrive.

We want GSK to be a place where people feel inspired, encouraged and challenged to be the best they can be.

A place where they can be themselves - feeling welcome, valued and included. Where they can keep growing and look after their wellbeing. So, if you share our ambition, join us at this exciting moment in our journey to get Ahead Together.

Find out more:
Annual Report 2021

We're combining the power of genetic and genomic insights into what causes disease, with the speed and scale of artificial intelligence and machine learning (AI/ML) to make better predictions about who a treatment might work for, and why.

We believe this powerful combination of data and technology holds the key to fundamentally transforming medical discovery for the better, improving R&D success rates and shaping how even the most challenging diseases, like neurological conditions and cancer, can be both prevented and treated.

In 2021 we delivered four major product approvals: Cabenuva for HIV, Jemperli for endometrial cancer, Xevudy for COVID-19 and Apretude, our new long-acting medicine for HIV prevention.

Find out more:
Our approach to R&D.

LI-GSK

If you have a disability and require assistance during the course of the selection process, you will have the opportunity to let us know what specifi